Junshi Biosciences Announces NMPA Acceptance of Investigational New Drug Application for JS014
SHANGHAI, China, June 28, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated